Follow-up Study to Monitor the Efficacy and Safety of the Occlutech® mVSD Cases
Condition(s):Muscular Ventricular Septal DefectLast Updated:February 14, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Muscular Ventricular Septal DefectLast Updated:February 14, 2024Recruiting
Condition(s):Patent Ductus ArteriosusLast Updated:June 18, 2023Recruiting
Condition(s):Heart DiseasesLast Updated:August 14, 2023Recruiting
Condition(s):Heart Failure With Preserved Ejection Fraction (HFpEF); Heart Failure With Reduced Ejection Fraction (HFrEF)Last Updated:October 26, 2023Active, not recruiting
Condition(s):Stroke; Patent Foramen OvaleLast Updated:March 22, 2024Recruiting
Condition(s):Secundum Atrial Septal DefectsLast Updated:July 27, 2020Completed
Condition(s):Heart FailureLast Updated:November 14, 2023Recruiting
Condition(s):Perimembranous Ventricular Septal DefectLast Updated:February 15, 2024Active, not recruiting
Condition(s):Stroke; PFO – Patent Foramen OvaleLast Updated:October 18, 2023Active, not recruiting
Condition(s):Heart Failure Low Output; Heart FailureLast Updated:September 15, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.